Search research articles
Contact Us
Filters
Showing results (701-710 of 1,482) with videos related to
Page
of 149
Sort By:
Cancer
|
February 13, 2026
Clinical, genetic, and familial features of POT1 tumor predisposition syndrome
Courtney D DiNardo, Jennifer Croden, Hiam M Abdel-Salam, et al.
Blood Neoplasia
|
August 4, 2025
PPARγ-induced upregulation of fatty acid metabolism confers resistance to venetoclax and decitabine therapy in AML
Kotoko Yamatani, Tatsuro Watanabe, Kaori Saito, et al.
Italian Journal of Pediatrics
|
February 14, 2024
Record of strep throat infections in Italy: what is needed to know about penicillin allergy? The point of view from the Italian Society of Pediatric Allergy and Immunology (SIAIP)
Maria De Filippo, Angela Klain, Ilaria Brambilla, et al.
International Journal of Molecular Sciences
|
May 27, 2026
Multidisciplinary Management of Malignant Phyllodes Tumours of the Breast: A Case-Based Illustration and Systematic Review
Greta Di Stefano, Graziella Marino, Alexios Thodas, et al.
Hematology, Transfusion and Cell Therapy
|
September 16, 2022
Detection of alloimmunization in Glanzmann Thrombasthenia and Bernard-Soulier Syndrome: Data from a Brazilian Center
Caroline Gabe, Karen Chinoca Ziza, Natália Durazzo, et al.
American Journal of Hematology
|
October 14, 2017
Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors
Ahmad Alhuraiji, Hagop Kantarjian, Prajwal Boddu, et al.
Leukemia & Lymphoma
|
August 19, 2025
Mortality and relapse dynamics in AML after three years of complete remission
Samuel Urrutia, Wei-Ying Jen, Koji Sasaki, et al.
Injury
|
December 27, 2014
Assessing trauma care provider judgement in the prediction of need for life-saving interventions
Amechi N Anazodo, Sarah B Murthi, M Kirsten Frank, et al.
Leukemia & Lymphoma
|
March 30, 2026
A phase I open label study of fostamatinib, a SYK inhibitor, in patients with lower-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
J Croden, G Garcia-Manero, K Chien, et al.
Transfusion
|
July 19, 2020
FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients
Abel Costa Neto, Flávia Santos, Ingrid Ribeiro, et al.
Page
of 149
Search research articles
Search
Showing results (701-710 of 1,482) with videos related to
Sort By:
Page
of 149
Cancer
|
February 13, 2026
Clinical, genetic, and familial features of POT1 tumor predisposition syndrome
Courtney D DiNardo, Jennifer Croden, Hiam M Abdel-Salam, et al.
Blood Neoplasia
|
August 4, 2025
PPARγ-induced upregulation of fatty acid metabolism confers resistance to venetoclax and decitabine therapy in AML
Kotoko Yamatani, Tatsuro Watanabe, Kaori Saito, et al.
Italian Journal of Pediatrics
|
February 14, 2024
Record of strep throat infections in Italy: what is needed to know about penicillin allergy? The point of view from the Italian Society of Pediatric Allergy and Immunology (SIAIP)
Maria De Filippo, Angela Klain, Ilaria Brambilla, et al.
International Journal of Molecular Sciences
|
May 27, 2026
Multidisciplinary Management of Malignant Phyllodes Tumours of the Breast: A Case-Based Illustration and Systematic Review
Greta Di Stefano, Graziella Marino, Alexios Thodas, et al.
Hematology, Transfusion and Cell Therapy
|
September 16, 2022
Detection of alloimmunization in Glanzmann Thrombasthenia and Bernard-Soulier Syndrome: Data from a Brazilian Center
Caroline Gabe, Karen Chinoca Ziza, Natália Durazzo, et al.
American Journal of Hematology
|
October 14, 2017
Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors
Ahmad Alhuraiji, Hagop Kantarjian, Prajwal Boddu, et al.
Leukemia & Lymphoma
|
August 19, 2025
Mortality and relapse dynamics in AML after three years of complete remission
Samuel Urrutia, Wei-Ying Jen, Koji Sasaki, et al.
Injury
|
December 27, 2014
Assessing trauma care provider judgement in the prediction of need for life-saving interventions
Amechi N Anazodo, Sarah B Murthi, M Kirsten Frank, et al.
Leukemia & Lymphoma
|
March 30, 2026
A phase I open label study of fostamatinib, a SYK inhibitor, in patients with lower-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
J Croden, G Garcia-Manero, K Chien, et al.
Transfusion
|
July 19, 2020
FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients
Abel Costa Neto, Flávia Santos, Ingrid Ribeiro, et al.
Page
of 149